Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

Homocysteine Studies Collaboration.

JAMA. 2002 Oct 23-30;288(16):2015-22.

PMID:
12387654
2.

Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention.

Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM.

Arch Intern Med. 1998 Apr 27;158(8):862-7.

PMID:
9570171
3.

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

Fibrinogen Studies Collaboration, Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, Pekkanen J, D'Agostino R, Kannel WB, Wilson PW, Tofler G, Arocha-Piñango CL, Rodriguez-Larralde A, Nagy E, Mijares M, Espinosa R, Rodriquez-Roa E, Ryder E, Diez-Ewald MP, Campos G, Fernandez V, Torres E, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen JT, Nyyssönen K, Tuomainen TP, Hedblad B, Lind P, Loewel H, Koenig W, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Després JP, Dagenais GR, Tunstall-Pedoe H, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Rudnicka A, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Kromhout D, Dickinson A, Ireland B, Juzwishin K, Kaptoge S, Lewington S, Memon A, Sarwar N, Walker M, Wheeler J, White I, Wood A.

JAMA. 2005 Oct 12;294(14):1799-809. Erratum in: JAMA. 2005 Dec 14;294(22):2848.

PMID:
16219884
4.

Homocysteine, renal function, and risk of cardiovascular disease.

Clarke R, Lewington S, Landray M.

Kidney Int Suppl. 2003 May;(84):S131-3.

PMID:
12694328
5.

MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG; MTHFR Studies Collaboration Group.

JAMA. 2002 Oct 23-30;288(16):2023-31.

PMID:
12387655
6.

Homocysteine and ischaemic heart disease in the Caerphilly cohort.

Ubbink JB, Fehily AM, Pickering J, Elwood PC, Vermaak WJ.

Atherosclerosis. 1998 Oct;140(2):349-56.

PMID:
9862278
7.

Blood glucose and risk of cardiovascular disease in the Asia Pacific region.

Lawes CM, Parag V, Bennett DA, Suh I, Lam TH, Whitlock G, Barzi F, Woodward M; Asia Pacific Cohort Studies Collaboration.

Diabetes Care. 2004 Dec;27(12):2836-42.

PMID:
15562194
8.

Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: a systematic review and meta-analysis.

Afshin A, Micha R, Khatibzadeh S, Mozaffarian D.

Am J Clin Nutr. 2014 Jul;100(1):278-88. doi: 10.3945/ajcn.113.076901. Epub 2014 Jun 4. Review.

9.

Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.

Heinz J, Kropf S, Luley C, Dierkes J.

Am J Kidney Dis. 2009 Sep;54(3):478-89. doi: 10.1053/j.ajkd.2009.01.266. Epub 2009 Apr 8.

PMID:
19359080
10.

Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease.

Tanne D, Haim M, Goldbourt U, Boyko V, Doolman R, Adler Y, Brunner D, Behar S, Sela BA.

Stroke. 2003 Mar;34(3):632-6. Epub 2003 Feb 20.

11.
12.

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M.

JAMA. 2004 Feb 4;291(5):565-75.

PMID:
14762035
13.

Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese.

Iso H, Moriyama Y, Sato S, Kitamura A, Tanigawa T, Yamagishi K, Imano H, Ohira T, Okamura T, Naito Y, Shimamoto T.

Circulation. 2004 Jun 8;109(22):2766-72. Epub 2004 May 24.

14.
15.

Homocysteine and risk of cardiovascular disease among postmenopausal women.

Ridker PM, Manson JE, Buring JE, Shih J, Matias M, Hennekens CH.

JAMA. 1999 May 19;281(19):1817-21.

PMID:
10340369
16.

Relationship between homocysteine and cardiovascular diseases in older adults.

Kuo HK.

J Am Geriatr Soc. 2004 Nov;52(11):1955-6. No abstract available.

PMID:
15507079
17.

Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.

Clarke R, Lewington S, Sherliker P, Armitage J.

Curr Opin Clin Nutr Metab Care. 2007 Jan;10(1):32-9. Review.

PMID:
17143052
18.
19.

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.

Prospective Studies Collaboration, Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R.

Lancet. 2007 Dec 1;370(9602):1829-39. Review. Erratum in: Lancet. 2008 Jul 26;372(9635):292.

PMID:
18061058
20.

Homocysteine-lowering interventions for preventing cardiovascular events.

Martí-Carvajal AJ, Solà I, Lathyris D, Karakitsiou DE, Simancas-Racines D.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD006612. doi: 10.1002/14651858.CD006612.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;1:CD006612.

PMID:
23440809

Supplemental Content

Support Center